The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and di...
Saved in:
Published in | Metabolism, clinical and experimental Vol. 61; no. 2; pp. 242 - 249 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.02.2012
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0026-0495 1532-8600 1532-8600 |
DOI | 10.1016/j.metabol.2011.06.020 |
Cover
Abstract | Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the
χ
2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. |
---|---|
AbstractList | Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ² test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ 2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes.Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985,815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ(2) test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104,343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. Abstract Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be confirmed by a prospective study in other population groups. This study aimed to investigate whether the strong association of cancer and diabetes is independent from the influence of hypertension, dyslipidemia, and gout in the Taiwanese population. A total of 985 815 study subjects were identified from the National Health Insurance in 1997 and followed up from 1998 to 2009. The demographic characteristics between patients with diabetes and cancer, including age, sex, hypertension, dyslipidemia, and gout, were analyzed using the χ2 test. Cox proportional hazard regression models were used to determine the independent effects of diabetes on the risks of cancer. A total of 104 343 diabetic patients were followed up from 1998 to 2009. After adjusting for sex, age, hypertension, dyslipidemia, and gout, the incidences of cancer at any site and in the liver, colon, lungs, and prostate in diabetic patients were independently higher, with risk ratios of 1.56 (95% confidence interval [CI], 1.43-1.71), 1.67 (95% CI, 1.39-2.01), 1.75 (95% CI, 1.49-2.06), 1.54 (95% CI, 1.26-1.88), and 1.56 (95% CI, 1.19-2.04), respectively. Only breast cancer did not show any clinical significance. There was an increased incidence of cancer at any site in the diabetic patients compared with nondiabetic subjects. The most common cancers were liver, colon, lung, breast, and prostate cancer; and except for breast cancer, their incidences increased independently of hypertension, dyslipidemia, and gout in patients with diabetes. |
Author | Shin, Shyi-Jang Lin, Kun-Der Hsiao, Pi-Jung Lee, Mei-Yueh |
Author_xml | – sequence: 1 givenname: Mei-Yueh surname: Lee fullname: Lee, Mei-Yueh organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan – sequence: 2 givenname: Kun-Der surname: Lin fullname: Lin, Kun-Der organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan – sequence: 3 givenname: Pi-Jung surname: Hsiao fullname: Hsiao, Pi-Jung organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan – sequence: 4 givenname: Shyi-Jang surname: Shin fullname: Shin, Shyi-Jang email: sjshin@kmu.edu.tw organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25563779$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21820134$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkktv1DAUhS1URKcDPwHkDaKLmcFO4jyEAKGKl1SJBcPacpybzh0SO9hOq_k3_ak4M1MhVYKyyUM65_P1ueeMnBhrgJDnnK044_nr7aqHoGrbrRLG-YrlK5awR2TGRZosy5yxEzJjLMmXLKvEKTnzfssYK4oyf0JOE15GV5rNyO16A1R5bzWqgNZQ29IGVQ0BPO2h6zCMnt5g2NAOr8EtqLadNQvajeZqQZVp6OCsDyoA1cpocBQ9RdPAAPFhwgTc7AZwAYzHybn_63DABnpUB8aVHUN00bXCG2XAAx3iONHun5LHreo8PDu-5-THp4_riy_Ly2-fv158uFxqkeZhWYFoyjptygISVpdtq0ReN1mZZEJXbQwlBa5SzpRQPFE8rVnW8rYushhJ3VZVOievDtx4nV8j-CB79DoGEMexo5cVL0qRZxE0J-f_VPIiTYXIOZugL47Sse6hkYPDXrmdvMs_Cl4eBcpr1bUuRoj-jy5y0qKYQG8OOh3D9g5aqTHsFxacwk5yJqdWyK08tkJOrZAsl7EV0S3uue8OeMj3_uCDGPw1gpNex6VoaNCBDrKx-CDh3T2C7tBgvOpP2IHf2tGZuFXJpU8kk9-nxk6F5Tx-sX2Cb_8O-I8BfgNMtP-R |
CitedBy_id | crossref_primary_10_1016_j_esmoop_2022_100518 crossref_primary_10_1016_j_metabol_2012_03_011 crossref_primary_10_1007_s00125_017_4229_z crossref_primary_10_1021_acs_analchem_4c04671 crossref_primary_10_1634_theoncologist_2013_0177 crossref_primary_10_1016_j_ejca_2014_08_007 crossref_primary_10_1021_acs_jnatprod_1c00014 crossref_primary_10_3892_ol_2017_7370 crossref_primary_10_1016_j_prnil_2018_11_001 crossref_primary_10_3390_cells8040326 crossref_primary_10_1371_journal_pone_0101553 crossref_primary_10_1016_j_lungcan_2014_09_012 crossref_primary_10_1371_journal_pone_0229176 crossref_primary_10_1021_es305295d crossref_primary_10_1039_D0RA06642G crossref_primary_10_1371_journal_pone_0056662 crossref_primary_10_22465_kjuo_2019_17_3_119 crossref_primary_10_3389_fonc_2019_01404 crossref_primary_10_1111_ajco_12084 crossref_primary_10_2337_dcS13_2031 crossref_primary_10_1177_1179554919835798 crossref_primary_10_1620_tjem_228_267 crossref_primary_10_1093_annonc_mdt017 crossref_primary_10_1007_s00592_013_0471_0 crossref_primary_10_1016_j_jseaes_2013_04_048 crossref_primary_10_1186_1471_2407_13_310 crossref_primary_10_1016_j_jtho_2017_01_021 crossref_primary_10_3892_ol_2017_7412 crossref_primary_10_1016_j_tem_2016_02_006 crossref_primary_10_1111_ecc_12084 crossref_primary_10_1007_s40200_019_00391_5 crossref_primary_10_1002_ijc_28989 crossref_primary_10_1210_jc_2018_02289 crossref_primary_10_6000_1929_2279_2014_03_04_3 crossref_primary_10_5534_wjmh_240022 crossref_primary_10_1016_j_ejca_2014_06_019 crossref_primary_10_1016_j_cmpb_2016_01_009 crossref_primary_10_1155_2012_801610 crossref_primary_10_3748_wjg_v20_i28_9541 crossref_primary_10_1002_ijc_31365 crossref_primary_10_3390_gidisord1020023 crossref_primary_10_1038_pcan_2012_40 crossref_primary_10_1111_cas_12235 crossref_primary_10_1186_s12885_015_1847_z crossref_primary_10_3390_cancers14030555 crossref_primary_10_1186_1471_2407_12_413 crossref_primary_10_7314_APJCP_2012_13_8_4097 crossref_primary_10_1007_s10654_013_9865_0 crossref_primary_10_1007_s11606_024_09076_z crossref_primary_10_1530_ERC_16_0222 crossref_primary_10_1016_j_ejca_2012_03_007 crossref_primary_10_1007_s11428_013_1068_5 crossref_primary_10_7759_cureus_40058 crossref_primary_10_1111_jdi_12112 crossref_primary_10_1371_journal_pone_0125421 crossref_primary_10_1007_s00592_012_0439_5 crossref_primary_10_6118_jmm_19014 crossref_primary_10_1093_carcin_bgu135 crossref_primary_10_1080_13543784_2017_1333104 crossref_primary_10_3389_fmed_2023_1118863 crossref_primary_10_3390_ijerph110908645 crossref_primary_10_7314_APJCP_2014_15_3_1447 crossref_primary_10_3390_jcm14020411 crossref_primary_10_1007_s00432_013_1407_3 crossref_primary_10_1016_j_critrevonc_2013_06_011 crossref_primary_10_3390_cancers13081982 crossref_primary_10_1097_CEJ_0000000000000361 crossref_primary_10_1002_cam4_1685 crossref_primary_10_1016_j_bmcl_2017_08_035 crossref_primary_10_1016_j_metabol_2014_04_014 crossref_primary_10_1155_2012_413782 crossref_primary_10_1155_2013_583786 crossref_primary_10_1016_j_genrep_2016_06_003 crossref_primary_10_1097_MD_0000000000006627 |
Cites_doi | 10.1093/jnci/dji375 10.2337/dc10-0666 10.1373/clinchem.2008.115352 10.1093/oxfordjournals.aje.a009534 10.1002/ijc.23192 10.1073/pnas.78.11.6858 10.1016/S0022-2275(20)32407-X 10.1677/ERC-09-0087 10.1016/j.cgh.2005.12.007 10.1200/JCO.2006.07.2777 10.1002/ijc.22717 10.1002/anr.1780321114 10.1038/nrc2734 10.2174/187152608784746501 10.1016/S1726-4901(09)70195-9 10.1093/annonc/mdm338 10.1016/S0003-9861(03)00283-2 10.1016/j.ejca.2006.01.012 10.2174/138920106779116928 10.1038/sj.ijir.3901031 10.1073/pnas.87.19.7638 10.1152/ajpendo.2001.280.5.E745 10.1158/1055-9965.EPI-06-0410 10.1111/j.1572-0241.2006.00725.x 10.1016/S0140-6736(06)68770-9 10.1016/0304-3835(88)90023-7 10.1136/gut.2004.052167 10.1097/CEJ.0b013e328313631a 10.7326/0003-4819-117-10-807 |
ContentType | Journal Article |
Copyright | 2012 Elsevier Inc. Elsevier Inc. 2015 INIST-CNRS Copyright © 2012 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2012 Elsevier Inc. – notice: Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2012 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 |
DOI | 10.1016/j.metabol.2011.06.020 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE AGRICOLA MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1532-8600 |
EndPage | 249 |
ExternalDocumentID | 21820134 25563779 10_1016_j_metabol_2011_06_020 S0026049511002009 1_s2_0_S0026049511002009 |
Genre | Journal Article |
GeographicLocations | Asia Taiwan |
GeographicLocations_xml | – name: Taiwan |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYJJ AAYWO ABBQC ABDPE ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACIEU ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AEVXI AFFNX AFJKZ AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 OHT ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UAP UHS WUQ X7M Z5R ZGI ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG G8K LCYCR ZA5 AAYXX ACLOT CITATION ~HD AGRNS IQODW CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-c536t-9e5d8b3d87e20b8ffa56bd48245c9f1533e1a310a5a12a13b04f1fb74077bf993 |
IEDL.DBID | .~1 |
ISSN | 0026-0495 1532-8600 |
IngestDate | Sun Sep 28 02:11:31 EDT 2025 Sat Sep 27 18:56:31 EDT 2025 Mon Jul 21 06:05:10 EDT 2025 Mon Jul 21 09:10:50 EDT 2025 Wed Oct 01 05:14:27 EDT 2025 Thu Apr 24 23:05:21 EDT 2025 Fri Feb 23 02:21:21 EST 2024 Sun Feb 23 10:20:06 EST 2025 Tue Aug 26 19:44:51 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Endocrinopathy Prostate disease Lung cancer Gout Diseases of the osteoarticular system Cardiovascular disease Hepatic disease Lipids Liver cancer Hyperuricemia Association Colon cancer Intestinal disease Bronchus disease Hyperlipemia Dyslipemia Male genital diseases Human Hypertension Lung disease Urinary system disease Respiratory disease Diabetes mellitus Metabolic diseases Malignant tumor Uric acid Microcristalline arthropathy Colonic disease Digestive diseases Purine Prostate cancer Microcrystal Endocrinology Cancer |
Language | English |
License | CC BY 4.0 Copyright © 2012 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-9e5d8b3d87e20b8ffa56bd48245c9f1533e1a310a5a12a13b04f1fb74077bf993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21820134 |
PQID | 1733556109 |
PQPubID | 24069 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_917856453 proquest_miscellaneous_1733556109 pubmed_primary_21820134 pascalfrancis_primary_25563779 crossref_citationtrail_10_1016_j_metabol_2011_06_020 crossref_primary_10_1016_j_metabol_2011_06_020 elsevier_sciencedirect_doi_10_1016_j_metabol_2011_06_020 elsevier_clinicalkeyesjournals_1_s2_0_S0026049511002009 elsevier_clinicalkey_doi_10_1016_j_metabol_2011_06_020 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-02-01 |
PublicationDateYYYYMMDD | 2012-02-01 |
PublicationDate_xml | – month: 02 year: 2012 text: 2012-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Metabolism, clinical and experimental |
PublicationTitleAlternate | Metabolism |
PublicationYear | 2012 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Chen (bb0025) 2009 Kaaks (bb0105) 1996; 7 Kern, Ranganathan, Li (bb0130) 2001; 280 Larsson, Orsini, Wolk (bb0060) 2005; 97 Giovannucci, Harlan, Archer (bb0020) 2009 Shuman (bb0110) 2008 Strasak, Rapp, Hilbe (bb0160) 2007; 18 Guerne, Terkeltaub, Zuraw (bb0175) 1989; 32 Betancourt-Albrecht, Cunningham (bb0095) 2003; 15 Larsson, Mantzoros, Wolk (bb0100) 2007; 121 Barrett-Connor (bb0090) 1992; 117 Peden, Hohman, Brown (bb0170) 1990; 87 Giovannucci, Harlan, Archer (bb0010) 2010; 33 Kasper, Giovannucci (bb0085) 2006; 15 Szlosarek, Charles, Balkwill (bb0135) 2006; 42 Hudgins, Hellerstein, Seidman (bb0140) 2000; 41 Chiang (bb0015) Stadler, Yeung, Furrer (bb0070) 1988; 38 Govindarajan, Ratnasinghe, Simmons (bb0080) 2007; 25 Boffetta, Nordenvall, Nyrén (bb0155) 2009; 18 (bb0035) 2008 Chen, Li, Chen (bb0055) 2006; 69 Heuson, Legros (bb0040) 1972; 32 Menendez, Vazquez-Martin, Ortega (bb0150) 2009; 55 Ames, Cathcart, Schweirs (bb0165) 1981; 78 Federico, Morgillo, Tuccillo (bb0115) 2007; 121 Cebioglu, Schild, Golubnitschaja (bb0125) 2008; 8 Lopez, Mathers, Ezzati (bb0030) 2006; 367 El-Serag, Hampel, Javadi (bb0045) 2006; 4 Limburg, Vierkant, Fredericksen (bb0065) 2006; 101 Lupu, Menendez (bb0145) 2006; 7 Davila, Morgan, Shaib (bb0050) 2005; 54 Yu, Pardoll, Jove (bb0180) 2009; 9 Vigneri, Frasca, Sciacca (bb0005) 2009; 16 Ohshima, Tatemichi, Sawa (bb0120) 2003; 417 Will, Galuska, Vinicor (bb0075) 1998; 147 Kaaks (10.1016/j.metabol.2011.06.020_bb0105) 1996; 7 Kern (10.1016/j.metabol.2011.06.020_bb0130) 2001; 280 Ames (10.1016/j.metabol.2011.06.020_bb0165) 1981; 78 Federico (10.1016/j.metabol.2011.06.020_bb0115) 2007; 121 Barrett-Connor (10.1016/j.metabol.2011.06.020_bb0090) 1992; 117 Shuman (10.1016/j.metabol.2011.06.020_bb0110) 2008 Boffetta (10.1016/j.metabol.2011.06.020_bb0155) 2009; 18 Govindarajan (10.1016/j.metabol.2011.06.020_bb0080) 2007; 25 Kasper (10.1016/j.metabol.2011.06.020_bb0085) 2006; 15 Davila (10.1016/j.metabol.2011.06.020_bb0050) 2005; 54 (10.1016/j.metabol.2011.06.020_bb0035) 2008 Vigneri (10.1016/j.metabol.2011.06.020_bb0005) 2009; 16 Chen (10.1016/j.metabol.2011.06.020_bb0025) 2009 Betancourt-Albrecht (10.1016/j.metabol.2011.06.020_bb0095) 2003; 15 Strasak (10.1016/j.metabol.2011.06.020_bb0160) 2007; 18 Chen (10.1016/j.metabol.2011.06.020_bb0055) 2006; 69 Lupu (10.1016/j.metabol.2011.06.020_bb0145) 2006; 7 Limburg (10.1016/j.metabol.2011.06.020_bb0065) 2006; 101 Peden (10.1016/j.metabol.2011.06.020_bb0170) 1990; 87 Giovannucci (10.1016/j.metabol.2011.06.020_bb0010) 2010; 33 Ohshima (10.1016/j.metabol.2011.06.020_bb0120) 2003; 417 Cebioglu (10.1016/j.metabol.2011.06.020_bb0125) 2008; 8 Yu (10.1016/j.metabol.2011.06.020_bb0180) 2009; 9 Lopez (10.1016/j.metabol.2011.06.020_bb0030) 2006; 367 Larsson (10.1016/j.metabol.2011.06.020_bb0060) 2005; 97 El-Serag (10.1016/j.metabol.2011.06.020_bb0045) 2006; 4 Will (10.1016/j.metabol.2011.06.020_bb0075) 1998; 147 Szlosarek (10.1016/j.metabol.2011.06.020_bb0135) 2006; 42 Hudgins (10.1016/j.metabol.2011.06.020_bb0140) 2000; 41 Larsson (10.1016/j.metabol.2011.06.020_bb0100) 2007; 121 Giovannucci (10.1016/j.metabol.2011.06.020_bb0020) 2009 Heuson (10.1016/j.metabol.2011.06.020_bb0040) 1972; 32 Chiang (10.1016/j.metabol.2011.06.020_bb0015) Menendez (10.1016/j.metabol.2011.06.020_bb0150) 2009; 55 Guerne (10.1016/j.metabol.2011.06.020_bb0175) 1989; 32 Stadler (10.1016/j.metabol.2011.06.020_bb0070) 1988; 38 |
References_xml | – volume: 69 start-page: 146 year: 2006 end-page: 152 ident: bb0055 article-title: Sero-prevalence of hepatitis B and C in type 2 diabetic patients publication-title: J Chinese Med Assoc – volume: 121 start-page: 2381 year: 2007 end-page: 2386 ident: bb0115 article-title: Chronic inflammation and oxidative stress in human carcinogenesis publication-title: Int J Cancer – volume: 4 start-page: 369 year: 2006 end-page: 380 ident: bb0045 article-title: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence publication-title: Clin Gastroenterol Hepatol – year: 2008 ident: bb0110 publication-title: National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007 – volume: 18 start-page: 1893 year: 2007 end-page: 1897 ident: bb0160 article-title: The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women publication-title: Ann Oncol – volume: 42 start-page: 745 year: 2006 end-page: 750 ident: bb0135 article-title: Tumour necrosis factor–alpha as a tumour promoter publication-title: Euro J Cancer – volume: 15 start-page: S14 year: 2003 end-page: S20 ident: bb0095 article-title: Hypo-gonadism and diabetes publication-title: Int J Impot Res – ident: bb0015 article-title: Bureau of National Health Insurance – volume: 117 start-page: 807 year: 1992 end-page: 811 ident: bb0090 article-title: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus publication-title: Ann Intern Med – volume: 54 start-page: 533 year: 2005 end-page: 539 ident: bb0050 article-title: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study publication-title: Gut – volume: 78 start-page: 6858 year: 1981 end-page: 6862 ident: bb0165 article-title: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis publication-title: Proc Natl Acad Sci U S A – year: 2009 ident: bb0025 publication-title: Department of Health – volume: 25 start-page: 1476 year: 2007 end-page: 1481 ident: bb0080 article-title: Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes publication-title: J Clin Oncol – volume: 87 start-page: 7638 year: 1990 end-page: 7642 ident: bb0170 article-title: Uric acid is a major antioxidant in human nasal airway secretions publication-title: Proc Natl Acad Sci U S A – volume: 16 start-page: 1103 year: 2009 end-page: 1123 ident: bb0005 article-title: Diabetes and cancer publication-title: Endocr Relat Cancer – year: 2009 ident: bb0020 publication-title: IDF diabetes Atlas [article online] – volume: 367 start-page: 1747 year: 2006 end-page: 1757 ident: bb0030 article-title: Global and regional burden of disease and risk factors, 200: systematic analysis of population health data publication-title: Lancet – volume: 32 start-page: 226 year: 1972 end-page: 232 ident: bb0040 article-title: Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction publication-title: Cancer Res – volume: 7 start-page: 483 year: 2006 end-page: 493 ident: bb0145 article-title: Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? publication-title: Curr Pharma Biotech – volume: 8 start-page: 76 year: 2008 end-page: 87 ident: bb0125 article-title: Diabetes mellitus as a risk factor for cancer: stress or viral etiology? publication-title: Infect Disord Drug Targets – volume: 280 start-page: E745 year: 2001 end-page: E751 ident: bb0130 article-title: Adipose tissue tumor necrosis factor and interleukin- 6 expression in human obesity and insulin resistance publication-title: Am J Physiol Endocrinol Metabol – volume: 121 start-page: 856 year: 2007 end-page: 862 ident: bb0100 article-title: Diabetes mellitus and risk of breast cancer: a meta-analysis publication-title: Int J Cancer – volume: 9 start-page: 798 year: 2009 end-page: 809 ident: bb0180 article-title: STATs in cancer inflammation and immunity: a leading role for STAT3 publication-title: Nat Rev Cancer – volume: 33 start-page: 1674 year: 2010 end-page: 1685 ident: bb0010 article-title: Diabetes and cancer: a consensus report publication-title: Diabetes Care – volume: 41 start-page: 595 year: 2000 end-page: 604 ident: bb0140 article-title: Relationship between carbohydrate-induced hyper-triglyceridemia and fatty acid synthesis in lean and obese subjects publication-title: J Lipid Res – volume: 15 start-page: 2056 year: 2006 end-page: 2062 ident: bb0085 article-title: A meta-analysis of diabetes mellitus and the risk of prostate cancer publication-title: Cancer Epidemiol Biomarkers Prevent – volume: 32 start-page: 1443 year: 1989 end-page: 1452 ident: bb0175 article-title: Inflammatory micro-crystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes publication-title: Arthritis Rheum – volume: 97 start-page: 1679 year: 2005 end-page: 1687 ident: bb0060 article-title: Diabetes mellitus and risk of colorectal cancer: a meta-analysis publication-title: J Natl Cancer Inst – year: 2008 ident: bb0035 publication-title: World cancer report – volume: 55 start-page: 425 year: 2009 end-page: 438 ident: bb0150 article-title: Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer publication-title: Clin Chemistry – volume: 101 start-page: 1872 year: 2006 end-page: 1879 ident: bb0065 article-title: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population based, retrospective cohort study publication-title: Am J Gastroenterol – volume: 18 start-page: 127 year: 2009 end-page: 132 ident: bb0155 article-title: A prospective study of gout and cancer publication-title: Eur J Cancer Prev – volume: 147 start-page: 816 year: 1998 end-page: 825 ident: bb0075 article-title: Colorectal cancer: another complication of diabetes mellitus? publication-title: Am J Epidemiol – volume: 38 start-page: 315 year: 1988 end-page: 320 ident: bb0070 article-title: Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer publication-title: Cancer Letters – volume: 7 start-page: 605 year: 1996 end-page: 625 ident: bb0105 article-title: Nutrition, hormones, and breast cancer: is insulin the missing link? publication-title: Cancer Causes Control – volume: 417 start-page: 3 year: 2003 end-page: 11 ident: bb0120 article-title: Chemical basis of inflammation -induced carcinogenesis publication-title: Arch Biochem Biophys – year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0025 – volume: 97 start-page: 1679 year: 2005 ident: 10.1016/j.metabol.2011.06.020_bb0060 article-title: Diabetes mellitus and risk of colorectal cancer: a meta-analysis publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dji375 – volume: 33 start-page: 1674 year: 2010 ident: 10.1016/j.metabol.2011.06.020_bb0010 article-title: Diabetes and cancer: a consensus report publication-title: Diabetes Care doi: 10.2337/dc10-0666 – volume: 55 start-page: 425 year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0150 article-title: Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer publication-title: Clin Chemistry doi: 10.1373/clinchem.2008.115352 – volume: 147 start-page: 816 year: 1998 ident: 10.1016/j.metabol.2011.06.020_bb0075 article-title: Colorectal cancer: another complication of diabetes mellitus? publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a009534 – year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0020 – volume: 121 start-page: 2381 year: 2007 ident: 10.1016/j.metabol.2011.06.020_bb0115 article-title: Chronic inflammation and oxidative stress in human carcinogenesis publication-title: Int J Cancer doi: 10.1002/ijc.23192 – volume: 78 start-page: 6858 year: 1981 ident: 10.1016/j.metabol.2011.06.020_bb0165 article-title: Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.78.11.6858 – volume: 41 start-page: 595 year: 2000 ident: 10.1016/j.metabol.2011.06.020_bb0140 article-title: Relationship between carbohydrate-induced hyper-triglyceridemia and fatty acid synthesis in lean and obese subjects publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)32407-X – volume: 16 start-page: 1103 year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0005 article-title: Diabetes and cancer publication-title: Endocr Relat Cancer doi: 10.1677/ERC-09-0087 – volume: 4 start-page: 369 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0045 article-title: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2005.12.007 – volume: 25 start-page: 1476 year: 2007 ident: 10.1016/j.metabol.2011.06.020_bb0080 article-title: Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes publication-title: J Clin Oncol doi: 10.1200/JCO.2006.07.2777 – volume: 121 start-page: 856 year: 2007 ident: 10.1016/j.metabol.2011.06.020_bb0100 article-title: Diabetes mellitus and risk of breast cancer: a meta-analysis publication-title: Int J Cancer doi: 10.1002/ijc.22717 – volume: 32 start-page: 1443 year: 1989 ident: 10.1016/j.metabol.2011.06.020_bb0175 article-title: Inflammatory micro-crystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes publication-title: Arthritis Rheum doi: 10.1002/anr.1780321114 – volume: 9 start-page: 798 year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0180 article-title: STATs in cancer inflammation and immunity: a leading role for STAT3 publication-title: Nat Rev Cancer doi: 10.1038/nrc2734 – volume: 8 start-page: 76 year: 2008 ident: 10.1016/j.metabol.2011.06.020_bb0125 article-title: Diabetes mellitus as a risk factor for cancer: stress or viral etiology? publication-title: Infect Disord Drug Targets doi: 10.2174/187152608784746501 – year: 2008 ident: 10.1016/j.metabol.2011.06.020_bb0110 – volume: 69 start-page: 146 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0055 article-title: Sero-prevalence of hepatitis B and C in type 2 diabetic patients publication-title: J Chinese Med Assoc doi: 10.1016/S1726-4901(09)70195-9 – volume: 18 start-page: 1893 year: 2007 ident: 10.1016/j.metabol.2011.06.020_bb0160 article-title: The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women publication-title: Ann Oncol doi: 10.1093/annonc/mdm338 – volume: 417 start-page: 3 year: 2003 ident: 10.1016/j.metabol.2011.06.020_bb0120 article-title: Chemical basis of inflammation -induced carcinogenesis publication-title: Arch Biochem Biophys doi: 10.1016/S0003-9861(03)00283-2 – volume: 42 start-page: 745 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0135 article-title: Tumour necrosis factor–alpha as a tumour promoter publication-title: Euro J Cancer doi: 10.1016/j.ejca.2006.01.012 – volume: 7 start-page: 483 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0145 article-title: Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? publication-title: Curr Pharma Biotech doi: 10.2174/138920106779116928 – volume: 15 start-page: S14 year: 2003 ident: 10.1016/j.metabol.2011.06.020_bb0095 article-title: Hypo-gonadism and diabetes publication-title: Int J Impot Res doi: 10.1038/sj.ijir.3901031 – year: 2008 ident: 10.1016/j.metabol.2011.06.020_bb0035 – volume: 87 start-page: 7638 year: 1990 ident: 10.1016/j.metabol.2011.06.020_bb0170 article-title: Uric acid is a major antioxidant in human nasal airway secretions publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.87.19.7638 – volume: 280 start-page: E745 year: 2001 ident: 10.1016/j.metabol.2011.06.020_bb0130 article-title: Adipose tissue tumor necrosis factor and interleukin- 6 expression in human obesity and insulin resistance publication-title: Am J Physiol Endocrinol Metabol doi: 10.1152/ajpendo.2001.280.5.E745 – volume: 15 start-page: 2056 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0085 article-title: A meta-analysis of diabetes mellitus and the risk of prostate cancer publication-title: Cancer Epidemiol Biomarkers Prevent doi: 10.1158/1055-9965.EPI-06-0410 – volume: 32 start-page: 226 year: 1972 ident: 10.1016/j.metabol.2011.06.020_bb0040 article-title: Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction publication-title: Cancer Res – volume: 101 start-page: 1872 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0065 article-title: Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population based, retrospective cohort study publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.00725.x – volume: 367 start-page: 1747 year: 2006 ident: 10.1016/j.metabol.2011.06.020_bb0030 article-title: Global and regional burden of disease and risk factors, 200: systematic analysis of population health data publication-title: Lancet doi: 10.1016/S0140-6736(06)68770-9 – volume: 7 start-page: 605 year: 1996 ident: 10.1016/j.metabol.2011.06.020_bb0105 article-title: Nutrition, hormones, and breast cancer: is insulin the missing link? publication-title: Cancer Causes Control – volume: 38 start-page: 315 year: 1988 ident: 10.1016/j.metabol.2011.06.020_bb0070 article-title: Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer publication-title: Cancer Letters doi: 10.1016/0304-3835(88)90023-7 – ident: 10.1016/j.metabol.2011.06.020_bb0015 – volume: 54 start-page: 533 year: 2005 ident: 10.1016/j.metabol.2011.06.020_bb0050 article-title: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study publication-title: Gut doi: 10.1136/gut.2004.052167 – volume: 18 start-page: 127 year: 2009 ident: 10.1016/j.metabol.2011.06.020_bb0155 article-title: A prospective study of gout and cancer publication-title: Eur J Cancer Prev doi: 10.1097/CEJ.0b013e328313631a – volume: 117 start-page: 807 year: 1992 ident: 10.1016/j.metabol.2011.06.020_bb0090 article-title: Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus publication-title: Ann Intern Med doi: 10.7326/0003-4819-117-10-807 |
SSID | ssj0007786 |
Score | 2.325903 |
Snippet | Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic factors, must be... Abstract Studies have shown an association between diabetes and cancer in Western countries; but this, as well as the influence of associated metabolic... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 242 |
SubjectTerms | Adult Aged Aged, 80 and over Asian Continental Ancestry Group - statistics & numerical data Biological and medical sciences breast neoplasms colon Colonic Neoplasms - complications Colonic Neoplasms - epidemiology Colonic Neoplasms - ethnology confidence interval Diabetes Complications - epidemiology Diabetes Complications - ethnology diabetes mellitus Diabetes Mellitus - epidemiology Diabetes Mellitus - ethnology Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinology & Metabolism Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Gastroenterology. Liver. Pancreas. Abdomen gout Gout - epidemiology Gout - ethnology health insurance Humans hyperlipidemia Hyperlipidemias - epidemiology Hyperlipidemias - ethnology hypertension Hypertension - epidemiology Hypertension - ethnology liver Liver Neoplasms - complications Liver Neoplasms - epidemiology Liver Neoplasms - ethnology Liver. Biliary tract. Portal circulation. Exocrine pancreas Lung Neoplasms - complications Lung Neoplasms - epidemiology Lung Neoplasms - ethnology lungs Male Medical sciences Middle Aged patients Prevalence prospective studies prostatic neoplasms Prostatic Neoplasms - complications Prostatic Neoplasms - epidemiology Prostatic Neoplasms - ethnology regression analysis risk sociodemographic characteristics Taiwan - epidemiology Tumors Vertebrates: anatomy and physiology, studies on body, several organs or systems |
Title | The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0026049511002009 https://www.clinicalkey.es/playcontent/1-s2.0-S0026049511002009 https://dx.doi.org/10.1016/j.metabol.2011.06.020 https://www.ncbi.nlm.nih.gov/pubmed/21820134 https://www.proquest.com/docview/1733556109 https://www.proquest.com/docview/917856453 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1532-8600 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007786 issn: 0026-0495 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect customDbUrl: eissn: 1532-8600 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007786 issn: 0026-0495 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1532-8600 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007786 issn: 0026-0495 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1532-8600 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007786 issn: 0026-0495 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIhASQlCghI-VkThudhMnTpxjVVEtoPbUSr1ZdmJDqjS72mSFuPBb-KnMxM6uKloVcUyUiR3PZPwmmXlDyEerc82trUIucgsBSmTDomAq1LEqM1OwqGBYnHx6li0u0i-X_HKPHI-1MJhW6X2_8-mDt_Zn5n4156u6xhpfwOKA75H0zBfxIfsX2PTs1y7NA_nRXJoHRM5w9a6KZ341uzY9LHXjmTyzWYRtv2_fn56sVAerZl27i7vx6LAvnTwjTz2gpEduzs_JnmkPyEPXYvLnAXl06n-evyC_wSSo2qmDLi0dP73SayTm7DcdxQ-ztMFsjSlFRut2ShtwCFOq2oqusEYE0Ckt0VjWtO5ove2j2-MNv0Ncux6y4lFyOGpq14VWuXt8W256kKLnqv6hsP8l9dyu3UtycfLp_HgR-gYNYcmTrA8Lwyuhk0rkhkVaWKt4pqtUsJSXhUUkaWIF-FFxFTMVJzpKbQzWAUFkri0go1dkv1225jWhwoiKpYopALBppQG1lSW3TGSWF2WaqYCko1pk6dnLsYlGI8c0tSvptSlRmxLT9VgUkNlWbOXoO-4TyEady7E2FbyphA3mPsH8NkHTeZ_QyVh2TEbyL7sNiNhK3jD9fxl0csMst8-IxHJIJRmQD6OdSvAb-DMINLvcwGzyJMHWqDg-veMaCOUFsg0lATl0Nr4bAIn_4yR98_-Tf0sewxFzKfDvyH6_3pj3gPB6PRle4Ql5cPT56-LsDw0KUmE |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBclZR8wxtZ9eR-dBnuME1u2bPmxlJV0bfKUQt-EZFudi5uE2GHsv9mfurtIdihr6dhjEp8l6y6n38l3vyPkq9Gp5sYUPhepgQAlMH6WMeXrUOVJmbEgY1icPJ0lk4v4-yW_3CPHXS0MplU63299-tZbu2_GbjXHq6rCGl_A4oDvkfTMFvHtxxx88oDsH52eTWa9Q0aKNJvpAcEzCOwKecbXo5uyhdWuHZlnMgqw8_fdW9SzlWpg4YzteHE_JN1uTScvyHOHKemRnfZLslcuDsgj22Xy1wF5PHXvz1-R32AVVO00QpeGdqev9Aa5OdtNQ_FsltaYsDGkSGq9GNIafMKQqkVBV1gmAgCV5mgva1o1tOpb6bZ4wx8Q2q63ifEouf1UV7YRrbL3uFpuWpCic1X9VNgCkzp61-Y1uTj5Nj-e-K5Hg5_zKGn9rOSF0FEh0pIFWhijeKKLWLCY55lBMFmGCiCk4ipkKox0EJsQDATiyFQbAEdvyGCxXJTvCBWlKFismAIMGxcagFuec8NEYniWx4nySNypReaOwBz7aNSyy1S7lk6bErUpMWOPBR4Z9WIry-DxkEDS6Vx25angUCXsMQ8JpncJlo1zC40MZcNkIP8yXY-IXvKW9f_LoIe3zLJ_RuSWQzZJj3zp7FSC68D3QaDZ5QZmk0YRdkfF8ek910A0L5BwKPLIW2vjuwGQ-z-M4vf_P_nP5MlkPj2X56ezsw_kKfzCbEb8RzJo15vyEwC-Vh-6P_QfXutVDA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+of+diabetes+mellitus+with+liver%2C+colon%2C+lung%2C+and+prostate+cancer+is+independent+of+hypertension%2C+hyperlipidemia%2C+and+gout+in+Taiwanese+patients&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Lee%2C+Mei-Yueh&rft.au=Lin%2C+Kun-Der&rft.au=Hsiao%2C+Pi-Jung&rft.au=Shin%2C+Shyi-Jang&rft.date=2012-02-01&rft.issn=0026-0495&rft.volume=61&rft.issue=2+p.242-249&rft.spage=242&rft.epage=249&rft_id=info:doi/10.1016%2Fj.metabol.2011.06.020&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00260495%2FS0026049511X00136%2Fcov150h.gif |